Pasireotide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 739 publications
Recurrent Cushing's disease due to postoperative seeding of tumor cells in the sphenoid sinus: a case report with review of the literature.
Journal: Endocrine journal
Published: June 10, 2026
Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions.
Journal: International journal of molecular sciences
Published: March 31, 2026
Resistant prolactinomas.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: March 28, 2026
Adenoma receptors and histologic characteristics determining management outcomes.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 06, 2026
Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches.
Journal: Drugs
Published: January 30, 2026
Current treatment landscape of acromegaly.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 26, 2026
Approach to the patient: Precision Medicine-Guided Evaluation and Treatment of Acromegaly.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 10, 2026
Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment.
Journal: Journal of medical economics
Published: January 10, 2026
Efficacy and safety of pharmacologic therapies in acromegaly: a systematic literature review and network meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 23, 2025
Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.
Journal: Frontiers in oncology
Published: December 15, 2025
Combination therapy of pasireotide and pegvisomant for aggressive acromegaly with an immature PIT1-lineage PitNET.
Journal: Endocrinology, diabetes & metabolism case reports
Published: November 19, 2025
Last Updated: 06/30/2026